# Protective Effect of Statin Against Negative Cardiovascular Remodeling and Organ Dysfunction After Acute Aortic Syndrome Surgery (PANDA III)

> **NCT04699279** · NA · RECRUITING · sponsor: **Nanjing Medical University** · enrollment: 300 (estimated)

## Conditions studied

- Acute Aortic Syndrome
- Aortopathy

## Interventions

- **DRUG:** Rosuvastatin 10mg

## Key facts

- **NCT ID:** NCT04699279
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-12-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04699279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04699279, "Protective Effect of Statin Against Negative Cardiovascular Remodeling and Organ Dysfunction After Acute Aortic Syndrome Surgery (PANDA III)". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT04699279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*